MET and neoplasm: Kinase profiling using KINOMEScan has revealed that, in addition to targeting FLT3/AURK signaling pathways, MET and AXL, two kinases that play a critical role in HCC tumor progression, invasion, and metastasis [32, 33], were potently inhibited by DBPR114.